Large-volume low apparent diffusion coefficient lesions predict poor survival in bevacizumab-treated glioblastoma patients Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Agents
  • Bevacizumab
  • Brain Neoplasms
  • Glioblastoma
  • Image Interpretation, Computer-Assisted

abstract

  • The volume of low-ADC lesions at the second post-bevacizumab scan predicted shorter OS. This suggests that low-ADC lesions may be considered important imaging markers and included in treatment decision algorithms.

publication date

  • May 2016

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4827045

Digital Object Identifier (DOI)

  • 10.1093/neuonc/nov268

PubMed ID

  • 26538618

Additional Document Info

start page

  • 735

end page

  • 43

volume

  • 18

number

  • 5